Concepedia
Statistics
Publications
3
Citations
898
H-Index
Active since
2009
Affiliations
University of Utah(Current)
Thrombolysis in Myocardial Infarction Study Group
The Heart Research Institute
Merck & Co., Inc., Rahway, NJ, USA (United States)
Cornell University
Sherry Xueyu Liu is an author at University of Utah specializing in clinical pharmacology, pharmacology, and pharmacotherapy.
Publications per year
2009–2012
Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
Christopher P. Cannon, Sukrut Shah, Hayes M. Dansky et al. · New England Journal of Medicine · 2010 · 754 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
Christopher P. Cannon, Hayes M. Dansky, Michael H. Davidson et al. · American Heart Journal · 2009 · 88 citations
Medicine, Pharmacology, Pharmacotherapy +3
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib
Michael H. Davidson, Sherry Xueyu Liu, Philip J. Barter et al. · Journal of Lipid Research · 2012 · 56 citations · Full text
Life Sciences, Pharmacology, Pharmacotherapy +17
1–3 of 3